Salarius Pharmaceuticals to Present at Biotech Showcase 2020

NEXT STORY
CytomX Therapeutics Provides Updates on Lead Clinical Programs and 2020 Portfolio Outlook
PREV STORY
Molecular Templates Appoints Corazon Dating Sanders, Ph.D., to its Board of Directors
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Welldoc Announces Expansion of Program with Leading Academic Medical Center to Evaluate BlueStar® Digital Therapeutic as a Means of Transforming Population Health in Primary Care

COLUMBIA, Md., Oct. 15, 2018 (GLOBE NEWSWIRE) -- Welldoc® today announced that one of ...

author_avatar
NASDAQ Market News

Intercept Pharmaceuticals Files New Drug Submission to Health Canada for Marketing Approval of Obeticholic Acid for the Treatment of Patients with Primary Biliary Cholangitis

New Drug Submission filed to Health Canada for obeticholic acid for PBCSubmission granted priority ...

author_avatar
NASDAQ Market News

CytomX to Present at the Jefferies 2017 London Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Nov. 01, 2017 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq:CTMX), ...

author_avatar
NASDAQ Market News